Adrenal Tumors - Pathogenesis and Therapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 100
SponsorUniversity of Wuerzburg
About this trial
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adrenal tumor detected by imaging
Disqualifiers
None
Trial population
Patients with adrenal tumors
Trial design
Design model
Case-control
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsGroup A: Tumor
Group B: control group
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Wuerzburg
Lead sponsor
Deutsche Krebshilfe e.V., Bonn (Germany)
Collaborator
German Federal Ministry of Education and Research
Collaborator
Source ClinicalTrials.gov